Novo Nordisk to launch lower-cost Ozempic copy in South Africa Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in ‌South Africa later this month, partnering ...

This week in Other Barks & Bites: Senator Thom Tillis (R-NC) indicates that the Patent Eligibility Restoration Act’s language could be changed to address concerns about gene patents; the Seventh ...